Copenhagen, Denmark – Global Headquarters
ORPHAZYME A/S in restructuring
Ole Maaløes Vej 3, DK-2200
Copenhagen N, Denmark
Phone: (+45) 39 17 82 72
If you are calling outside of working hours (Monday-Thursday: 8:00AM – 4:00PM CET, Friday: 8:00AM – 2.00 PM CET) and your call concerns a quality issue/product complaint or a side effect, please call: (+45) 20 83 63 97.
Reporting of Adverse Reactions:
Pharmacovigilance at Orphazyme aims to enhance patient care and patient safety in relation to the use of our drugs. We support public health programs by providing reliable, balanced information for the effective assessment of the risk-benefit profile of medicines. We take appropriate measures in order to collect and collate all reports of suspected adverse reactions associated with medicinal products for human use. To ensure ongoing patient safety, Regulatory agencies require companies like Orphazyme to continue studying the side effects of our products before and after approval.
We encourage all our patients and their health care providers to communicate with us about any possible side effects via Pharmacovigilance@orphazyme.com.
Physicians, patients and caregivers with medical or scientific enquiries, including questions on our clinical trial programs, please contact Orphazyme Medical Affairs at firstname.lastname@example.org.
Investor & Media Enquiries:
Anders Fink Vadsholt – Chief Executive Officer